AUSTIN, TX – Actor and filmmaker Mel Gibson described a series of personal anecdotes involving cancer recovery during a January 2025 appearance on The Joe Rogan Experience, drawing attention to a broader online conversation about alternative treatments.
During the discussion with host Joe Rogan, Gibson said that three individuals he knows had been diagnosed with Stage IV cancer and later no longer had detectable cancer.
“I have three friends. All three of them had stage four cancer… All three of them don’t have cancer right now, at all,” Gibson said during the episode.
When asked what the individuals had taken, Gibson responded that they used ivermectin and fenbendazole.
The conversation then expanded to include mentions of other substances, including methylene blue, with Rogan noting that some of these treatments are increasingly being discussed online. The exchange also touched on broader skepticism toward traditional medical systems, with comments suggesting that some alternative approaches may be overlooked.
Discussion Reflects Broader Online Trends
Mentions of drugs such as ivermectin and fenbendazole have circulated widely across social media and podcast platforms in recent years, often in connection with anecdotal reports of off-label or unconventional use.
Methylene blue, which was also referenced in the discussion, has historically been used for medical and industrial purposes and continues to be explored in various research settings.
Focus on Anecdotal Accounts
The exchange between Gibson and Rogan centered on personal experiences and observations rather than clinical data or formal studies. Neither the podcast segment nor the remarks included specific medical documentation, treatment protocols, or independently verified outcomes.
As with many podcast discussions of this nature, the conversation reflected a mix of personal testimony, emerging topics, and informal commentary rather than a structured medical analysis.
Ongoing Public Interest
Clips from the episode have since circulated online, contributing to continued public interest in alternative therapies and the role of anecdotal evidence in shaping health discussions.
Podcasts like The Joe Rogan Experience often feature long-form, unscripted conversations that can reach millions of listeners, frequently amplifying topics that are already gaining traction across digital platforms.
Key Facts and Details
| Topic | Details |
|---|---|
| Podcast | The Joe Rogan Experience |
| Guest | Mel Gibson |
| Approx. Date | January 2025 |
| Main Claim | Gibson said three acquaintances with Stage IV cancer later had no cancer |
| Substances Mentioned | Ivermectin, Fenbendazole, Methylene Blue |
| Nature of Discussion | Anecdotal, conversational |
| Evidence Presented | None cited during the exchange |
| Format | Long-form podcast interview |
Frequently Asked Questions
What did Mel Gibson say on Joe Rogan’s podcast?
During his appearance on The Joe Rogan Experience, Mel Gibson said that three people he knows had Stage IV cancer and later no longer had cancer. He attributed their reported recovery to the use of ivermectin and fenbendazole.
What drugs were mentioned in the discussion?
The conversation referenced ivermectin and fenbendazole, along with methylene blue. These substances were discussed in the context of anecdotal reports and online conversations about alternative treatments.
Is there evidence that these drugs cure cancer?
The podcast segment did not include clinical data, medical studies, or independently verified evidence supporting the claims. The discussion was based on personal anecdotes shared during the interview.
Where was this discussion recorded?
The episode of The Joe Rogan Experience was recorded in Austin, Texas, where the show is currently produced.
Why is this interview getting attention?
The clip has circulated online due to the nature of the claims and the popularity of both Mel Gibson and Joe Rogan. Discussions involving alternative treatments often generate strong public interest and debate.
Was the conversation a medical or scientific discussion?
No. The exchange was informal and conversational, reflecting personal experiences and opinions rather than a structured medical or scientific analysis.
